Antimalarials for treating rheumatoid arthritis.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Cochrane Database of Systematic Reviews

• Publication date

  2000-10-23

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/14651858.CD000959PMID 11034691PMCID PMC8407035
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Assessing the quality of reports of randomized clinical trials: is blinding necessary?

  1996cited by this paper
• Improving the quality of reporting of randomized controlled trials. The CONSORT statement.

  1996cited by this paper
• American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis.

  1995cited by this paper
• Tenidap in rheumatoid arthritis. A 24-week double-blind comparison with hydroxychloroquine-plus-piroxicam, and piroxicam alone.

  1995cited by this paper
• Identifying relevant studies for systematic reviews

  1995cited by this paper
• Systematic Reviews: Identifying relevant studies for systematic reviews

  1994cited by this paper
• Identifying relevant studies for systematic reviews.

  1994cited by this paper
• Meta-Analysis, Decision Analysis, and Cost-Effectiveness Analysis: Methods for Quantitative Synthesis in Medicine

  1994cited by this paper
• The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials.

  1993cited by this paper
• Hydroxychloroquine compared with placebo in rheumatoid arthritis. A randomized controlled trial.

  1993cited by this paper
• The American college of rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials

  1993cited by this paper
• Hydroxychloroquine Compared with Placebo in Rheumatoid Arthritis

  1993cited by this paper
• Should disease-modifying agents be used in mild rheumatoid arthritis?

  1991cited by this paper
• Effect Sizes for Interpreting Changes in Health Status

  1989cited by this paper
• Chloroquine and hydroxychloroquine therapy in rheumatoid arthritis.

  1962influential reference
• Hydroxychloroquine sulfate ("plaguenil") in treatment of rheumatoid arthritis.

  1962cited by this paper
• Hydroxychloroquine sulfate (“Plaquenil”) in treatment of rheumatoid arthritis

  1962cited by this paper
• Chloroquine Diphosphate in Rheumatoid Arthritis *

  1961cited by this paper
• Chloroquine in Rheumatoid Arthritis

  1960cited by this paper
• Amodiaquine and hydroxychloroquine in rheumatoid arthritis.

  1959cited by this paper
• A controlled study of chloroquine as an antirheumatic agent.

  1958cited by this paper
• Chloroquine therapy in rheumatoid arthritis.

  1957cited by this paper
• Chloroquine therapy in rheumatoid arthritis.

  1957cited by this paper
• Chloroquine and Rheumatoid Arthritis

  1956cited by this paper

• Management and treatment of early rheumatoid arthritis, process and barriers among rheumatologists in Spain: a Delphi consensus

  2025cites this paper
• Association between hydroxychloroquine concentrations and its efficacy and safety in Japanese patients with rheumatoid arthritis.

  2025cites this paper
• STOP-ing Rheumatoid Arthritis - Lessons Learned from the Latest Prevention Trial.

  2025cites this paper
• Prevention and detection of hydroxychloroquine-induced retinopathy in patients with systemic autoimmune diseases

  2025cites this paper
• An Update on the Benefits and Safety Profile of Hydroxychloroquine

  2024cites this paper
• Actualización del Documento de Consenso de la Sociedad Española de Reumatología sobre el uso de terapias biológicas y sintéticas dirigidas en la artritis reumatoide

  2024cites this paper
• Update of the Consensus Statement of the Spanish Society of Rheumatology on the use of biological and synthetic targeted therapies in rheumatoid arthritis.

  2024cites this paper
• Factors associated with secondary coronary artery disease in rheumatoid arthritis patients: A systematic review and meta-analysis based on observational studies.

  2023cites this paper
• Clinical and immunological effects of hydroxychloroquine in patients with active rheumatoid arthritis despite antirheumatic treatment.

  2022cites this paper
• Prognostic Impact of Genetic Variants of MECP2 and TIRAP on Clinical Outcomes of Systemic Lupus Erythematosus with and without Nephritis

  2021cites this paper
• Are Patients on Cyclophosphamide at Higher Risk of Covid-19 Complications?

  2021cites this paper
• The Efficiency of Hydroxychloroquine for the Treatment of Primary Sjögren’s Syndrome: A Systematic Review and Meta-Analysis

  2021cites this paper
• Antimalarial drugs—are they beneficial in rheumatic and viral diseases?—considerations in COVID-19 pandemic

  2021cites this paper
• The Therapeutic Landscape of Rheumatoid Arthritis: Current State and Future Directions

  2021cites this paper
• Update on the Pathomechanism, Diagnosis, and Treatment Options for Rheumatoid Arthritis

  2020cites this paper
• Of mice, microglia, and (wo)men: a case series and mechanistic investigation of hydroxychloroquine for complex regional pain syndrome

  2020cites this paper
• Conventional disease-modifying agents in rheumatoid arthritis – a review of their current use and role in treatment algorithms

  2020cites this paper
• An umbrella review of systematic reviews with meta-analyses evaluating positive and negative outcomes of Hydroxychloroquine and chloroquine therapy

  2020cites this paper
• A Review of Neutrophil Extracellular Traps (NETs) in Disease: Potential Anti-NETs Therapeutics

  2020cites this paper
• Rheumatic immune-related adverse events associated with cancer immunotherapy: A nationwide multi-center cohort.

  2020cites this paper
• Management der frühen rheumatoiden Arthritis

  2020cites this paper
• Hydroxychloroquine is a safe and effective steroid-sparing agent for immune checkpoint inhibitor–induced inflammatory arthritis

  2019cites this paper
• 2018 update of the APLAR recommendations for treatment of rheumatoid arthritis

  2019cites this paper
• Expanding horizons for clinical applications of chloroquine, hydroxychloroquine, and related structural analogues

  2019cites this paper
• Interferon activation in primary Sjögren’s syndrome: recent insights and future perspective as novel treatment target

  2018cites this paper
• Inflammatory arthritis in systemic sclerosis: What to do?

  2018cites this paper
• Perspectives on Rational Drug Design and Therapy for Pediatric Precision Medicine.

  2018cites this paper
• New phenylaniline derivatives as modulators of amyloid protein precursor metabolism.

  2018cites this paper
• Examining the role of ganglioside homeostasis in neurodegeneration and aging using MALDI imaging mass spectrometry

  2018cites this paper
• Activity-guided development of potent and selective toll-like receptor 9 antagonists.

  2018cites this paper
• [Chloroquine retinopathy].

  2018cites this paper
• Drugs Used in Rheumatic Disease

  2018cites this paper
• Chloroquine prevents acute kidney injury induced by lipopolysaccharide in rats via inhibition of inflammatory factors

  2017cites this paper
• To stop the erosion of hope: the DMARD category and the place of semantics in modern rheumatology

  2017cites this paper
• Is hydroxychloroquine effective in treating primary Sjogren’s syndrome: a systematic review and meta-analysis

  2017cites this paper
• Evidence‐based recommendations for the diagnosis and management of rheumatoid arthritis for non‐rheumatologists: Integrating systematic literature research and expert opinion of the Thai Rheumatism Association

  2017cites this paper
• Metabolic and cardiovascular benefits of hydroxychloroquine in patients with rheumatoid arthritis: a systematic review and meta-analysis

  2017cites this paper
• A Prototype Web Platform to Facilitate Public Engagement with Medical Evidence about Rheumatoid Arthtritis Medications

  2016cites this paper
• Hydroxychloroquine induces inhibition of collagen type II and oligomeric matrix protein COMP expression in chondrocytes

  2016cites this paper
• 2014 update of the Consensus Statement of the Spanish Society of Rheumatology on the use of biological therapies in rheumatoid arthritis.

  2015cites this paper
• Management of Children with Juvenile Idiopathic Arthritis

  2015cites this paper
• 55 – Nonimmunosuppressive disease-modifying antirheumatic drugs

  2015cites this paper
• Manipulating Autophagic Processes in Autoimmune Diseases: A Special Focus on Modulating Chaperone-Mediated Autophagy, an Emerging Therapeutic Target

  2015cites this paper
• 2014 update of the Consensus Statement of the Spanish Society of Rheumatology on the use of biological therapies in rheumatoid arthritis.

  2015cites this paper
• Inhibitory effect of chloroquine derivatives on presenilin 1 and ubiquilin 1 expression in Alzheimer's disease.

  2015cites this paper
• Chloroquine and chloroquinoline derivatives as models for the design of modulators of amyloid Peptide precursor metabolism.

  2015cites this paper
• Exacerbation of Psoriasis due to Hydroxychloroquine

  2015cites this paper
• Immunomodulators in managing geriatric rheumatoid arthritis

  2015cites this paper
• Sensitivity and Specificity of Multifocal Electroretinography in Detecting Chloroquine and Hydroxychloroquine retinal toxicity

  2015cites this paper
• Regular examinations for toxic maculopathy in long-term chloroquine or hydroxychloroquine users.

  2014cites this paper
• Randomised controlled trial of tumour necrosis factor inhibitors against combination intensive therapy with conventional disease-modifying antirheumatic drugs in established rheumatoid arthritis: the TACIT trial and associated systematic reviews.

  2014cites this paper
• Assessment of the treat-to-target strategy in patients with refractory rheumatoid arthritis

  2014cites this paper
• Long-term outcome of early rheumatoid arthritis : with special interest in comorbidity and permanent consequences of the disease

  2014cites this paper
• REVISTA BRASILEIRA DE REUMATOLOGIA

  2014cites this paper
• Current immunotherapy in rheumatoid arthritis.

  2013cites this paper
• Emerging Role of Endosomal Toll-Like Receptors in Rheumatoid Arthritis

  2013cites this paper
• Guidelines for the drug treatment of rheumatoid arthritis.

  2013cites this paper
• Ofatumumab for rheumatoid arthritis

  2013cites this paper
• Diretrizes para o tratamento da artrite reumatoide

  2013cites this paper
• Diretrizes para o tratamento da artrite reumatoide Guidelines for the drug treatment of rheumatoid arthritis

  2013cites this paper
• Ofatumumab for rheumatoid arthritis (Protocol)

  2013cites this paper
• medication into perspective: review of meta-analyses Putting the efficacy of psychiatric and general medicine

  2012cites this paper
• Brazilian Society of Rheumatology Consensus for the treatment of rheumatoid arthritis

  2012cites this paper
• Putting the efficacy of psychiatric and general medicine medication into perspective: review of meta-analyses

  2012cites this paper
• A Clinical and Economic Review of Disease-Modifying Antirheumatic Drugs

  2012cites this paper
• The initial treatment strategy and the long-term outcome of early rheumatoid arthritis with special interest in the FIN-RACo trial and the current Finnish practice

  2012cites this paper
• 2012 Brazilian Society of Rheumatology Consensus for the treatment of rheumatoid arthritis.

  2012cites this paper
• Modulation of cardiovascular risk factors and inflammation in rheumatic diseases

  2011cites this paper
• Interdisziplinäre Leitlinie Management der frühen rheumatoiden Arthritis

  2011cites this paper
• Minocycline and doxycycline therapy in community patients with rheumatoid arthritis: prescribing patterns, patient-level determinants of use, and patient-reported side effects

  2011cites this paper
• Rheumatoid Arthritis and Pregnancy

  2011influential citation
• Aggressive therapy in patients with early arthritis results in similar outcome compared with conventional care: the STREAM randomized trial

  2011cites this paper
• PHARMACOLOGY AND DRUG THERAPY

  2011cites this paper
• Management of Rheumatoid Arthritis: Consensus Recommendations From the Turkish League Against Rheumatism

  2011cites this paper
• New understanding and approaches to treatment in rheumatoid arthritis.

  2010cites this paper
• EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

  2010cites this paper
• Fluoxetine and citalopram exhibit potent antiinflammatory activity in human and murine models of rheumatoid arthritis and inhibit toll-like receptors.

  2010cites this paper
• EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

  2010cites this paper
• [Update of the Consensus Statement of the Spanish Society of Rheumatology on the management of biologic therapies in rheumatoid arthritis].

  2010cites this paper
• Consenso Brasileiro de Doenças Reumáticas: Atualização do Consenso Brasileiro no Diagnóstico e Tratamento da Artrite Reumatoide

  2009cites this paper
• Elderly Onset Rheumatoid Arthritis

  2009cites this paper
• Clinical approaches to early inflammatory arthritis

  2009cites this paper
• Abatacept for rheumatoid arthritis.

  2009cites this paper
• Disease-modifying antirheumatic drugs other than methotrexate in rheumatoid arthritis and seronegative arthritis

  2008cites this paper
• American College of Rheumatology quality indicators for rheumatoid arthritis: benchmarking, variability, and opportunities to improve quality of care using the electronic health record.

  2008cites this paper
• Assessing the Methodological Quality of Systematic Reviews: The Development of AMSTAR

  2008cites this paper
• Inhibitors of TLR8 Reduce TNF Production from Human Rheumatoid Synovial Membrane Cultures1

  2008cites this paper
• Atualização do Consenso Brasileiro no Diagnóstico e Tratamento da Artrite Reumatóide Update on the Brazilian Consensus for the Diagnosis and Treatment of Rheumatoid Arthritis

  2007cites this paper
• Update on the brazilian consensus for the diagnosis and treatment of rheumatoid arthritis

  2007cites this paper
• Efficacy and Safety of hydroxychloroquine sulphate in rheumatoid arthritis: a randomized, double-blind, placebo controlled clinical trial – an Indian experience

  2007cites this paper
• Measuring process of arthritis care: the Arthritis Foundation's quality indicator set for rheumatoid arthritis.

  2006cites this paper
• Mode of action of hydroxychloroquine in RA—evidence of an inhibitory effect on toll-like receptor signaling

  2006cites this paper
• Antipaludéens de synthèse

  2005cites this paper
• [Synthetic antimalarials].

  2005cites this paper
• Management Issues with Elderly-Onset Rheumatoid Arthritis

  2005cites this paper
• Patient education for adults with rheumatoid arthritis.

  2003cites this paper
• Number needed to treat (NNT): implication in rheumatology clinical practice

  2003cites this paper
• Practical Prescribing Guidelines for Rheumatoid Arthritis

  2003cites this paper
• antipalúdicos en el tratamiento de las enfermedades autoinmunes sistémicas y reumáticas

  2003cites this paper
• Patient education for adults with rheumatoid arthritis.

  2002cites this paper